“Merchants of Death” - BioNTech - predicts disappearing demand for its toxic C19 mRNA injections around the world

Rumour has it that BioNTech is owned by Fosun Pharma and that Fosun Pharma makes the mRNA component of the Pfizer/BioNTech C19 mRNA injections. Certainly neither Pfizer nor BioNTech does.

From here:

BioNTech shares slip on gloomy Covid vaccine sales outlook (cnbc.com)

Having killed or injured billions of people around the world with its unsafe and ineffective C19 mRNA injections, BioNTech announced its earnings and outlook yesterday.

“This year, the drugmaker expects Covid vaccine revenue to fall to 5 billion euros, or $5.4 billion, from 17.3 billion euros, or more than $18 billion in 2022.”

That is a fall of 70% in revenue. The Chinese will be desperately disappointed in their efforts to weaken the West. Still, the damage will last for years and will only increase, so the Chinese won’t be that concerned.

“the company added that it expects fewer primary series vaccinations and lower booster uptake this year. BioNTech also said it’s renegotiating its supply contract with the European Union’s executive body, which could potentially spread vaccine deliveries across multiple years and reduce volume.”

Maybe BioNTech owners are viewing bivalent doses sold in the US and concluding that the only uptake for their toxic injections is in places where political  or university campus mandates exist.

Pfizer/BioNTech has a 60% share of the US market for bivalent doses. Here is a chart for bivalent doses administered this year by week. Down from 1.4 million a week to around 300,000.

Onwards!

Please subscribe, or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan